This content is machine translated News in metastatic prostate cancer. What impact will the studies published in 2020/2021 have on clinical practice? The years 2020 and 2021 have brought some novelties in metastatic prostate cancer. Thus, with 177Lutetium-PSMA-617and the PARP inhibitor Olaparib, two new active substances are available. The latter is already… CME-Test
View Post 6 min This content is machine translated CAR-T cell therapy Paving the way to success With the increasing clinical application of CAR-T cells, the practical aspects of therapy are a growing concern. Which patients should receive treatment using CAR-T cells outside of clinical trials? What…
View Post 1 min This content is machine translated Pan-European survey Management of tumor pain – patient care needs. Advances in tumor pain management, as well as the increasing number of long-term survivors, have contributed significantly to a better understanding of patients’ needs during the course of the disease.…
View Post 2 min This content is machine translated Multiple myeloma Small protein is difficult for phagocytes to digest Multiple myeloma is a type of bone marrow cancer that mainly affects people over the age of 60 and in many cases cannot be cured. Researchers at the University Hospital…
View Post 3 min This content is machine translated Molecular precision oncology What are the benefits of cancer genome sequencing for children with cancer? For children with cancer who have relapsed, cancer genomic analyses can help make more accurate diagnoses, find appropriate therapy and delay disease progression. This is shown by the results of…
View Post 3 min This content is machine translated New study on patient participation Should sufferers attend tumor conferences? Finding the best treatment for sufferers with complex cancers – that’s what tumor conferences aim to do. Doctors from oncology, radiology, surgery, pathology and other disciplines talk about the disease…
View Post 3 min This content is machine translated New "keys" for eliminating cancer cells Hybrid active ingredients “Borinostats” use boron instead of carbon By bringing together pharmacy and inorganic chemistry, chemist Dr. Christoph Selg and his colleagues have succeeded in developing a group of promising potential active ingredients for cancer therapy: the so-called…
View Post 6 min This content is machine translated Lynch syndrome From suspicion to proper management Lynch syndrome, also known as HNPCC (hereditary non-polyposis colorectal cancer), is the most common inherited cause of colorectal cancer worldwide. In addition to preventive surgery, aspirin is also used for…
View Post 4 min This content is machine translated Hodgkin's disease Excess mortality after surviving disease: a search for causes Today, more than 80% of all patients with Hodgkin lymphoma can be cured, and in early stages even more than 90%. Nevertheless, the disease and its therapy have a significant…
View Post 3 min This content is machine translated Non-small cell lung cancer (NSCLC) New therapeutic option for metastatic NSCLC with METex14 skipping mutation. The growing understanding of tumor genetic mechanisms and the development of molecular diagnostics have enabled the development of targeted therapies, leading to significant advances in the treatment of lung cancer…
View Post 3 min This content is machine translated The somewhat different knowledge Where does the name “Sézary syndrome” actually come from? As a cutaneous T-cell lymphoma with an erythrodermic course, Sézary syndrome is a rare entity. Nevertheless, most physicians have encountered this prognostically unfavorable disease, at least in theory. This may…
